Daily Health Headlines

More Hispanics Treated at Breast Cancer Center After Obamacare

👤by HealthDay 0 comments 🕔Monday, September 26th, 2016

SUNDAY, Sept. 25, 2016 (HealthDay News) -- After the Affordable Care Act (ACA) was implemented in 2014, more Hispanic women received breast cancer treatment and enrolled in clinical trials at a California cancer center, a new study finds.

"Our study shows that with the implementation of the ACA in California, our cancer center's Hispanic breast cancer patient population increased significantly," Chloe Lalonde said in a news release from the American Association for Cancer Research.

"We also observed an increase in the proportion of Hispanic women who consented to be part of a national clinical trial, including a substantial increase in Spanish-speaking patients," Lalonde said. She was a clinical research coordinator at the University of California, San Diego, Moores Cancer Center during the study.

The researchers suspect the increase was from previously uninsured patients getting insurance under the ACA, said Lalonde, who is now a medical student at the Emory University School of Medicine in Atlanta.

For the study, the researchers compared the number of Hispanic women with newly diagnosed breast cancer who received care at the Moores Cancer Center before and after the implementation of the ACA, also known as Obamacare.

The study team focused on women treated between January 2010 and December 2013, and compared them to women treated between January 2014 and December 2015.

The investigators also looked at how many Hispanic women volunteered to participate in breast cancer treatment clinical trials before and after the health-reform law took effect. The study authors noted that it's important for clinical trials to represent diverse patient populations.

Before the legislation was passed, Hispanic women represented 10 percent of the Moores Cancer Center breast cancer patient population. After the ACA, that number rose to 16 percent in 2015, the findings showed.

And, more Hispanic women volunteered to participate in clinical trials after Obamacare took effect, the study authors said.

Before the health law was implemented, Hispanic women represented about 12 percent of women in a multicenter clinical trial of first-line chemotherapy. After Obamacare, the trial was about 22 percent Hispanic women.

There was also a sixfold increase in the number of Spanish-speaking women in the clinical trial, according to the report.

Although the study couldn't prove a cause-and-effect relationship, the study authors contend that policies, such as Obamacare, can have a big impact on access to care for cancer patients.

The researchers noted that their findings show changes seen at just one U.S. cancer center. More research is needed to see whether the health care law is helping to increase access to care in other regions.

The study findings were expected to be presented Sunday at a meeting of the American Association for Cancer Research in Fort Lauderdale. Findings presented at meetings are generally viewed as preliminary until published in a peer-reviewed journal.

-- Mary Elizabeth Dallas

Article Credits / Source


HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: American Association for Cancer Research, news release, Sept. 25, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cancer Articles

No Benefit From Routine Thyroid Cancer Screening: Task Force

No Benefit From Routine Thyroid Cancer Screening: Task Force0

TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation. It reaffirms a recommendation ...

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Depressed Women Less Likely to Get Best Breast Cancer Care: Study0

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...

Earnings Fall After a Child's Cancer Diagnosis

Earnings Fall After a Child's Cancer Diagnosis0

MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...

Monoclonal Antibodies

Monoclonal Antibodies0

home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

New Drug May Brighten Outlook for Advanced Breast Cancer

New Drug May Brighten Outlook for Advanced Breast Cancer0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...

View More Cancer Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!